← SynDRA
GSK-2245035
SynDRA canonical compound SYN0039638 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | TLR7 |
|---|
| Mechanism of action | toll-like receptor agonist |
|---|
| Indication | asthma |
|---|
| Disease area | pulmonary |
|---|
All known targets
Mechanisms of action (all sources)
- TLR7 AGONIST
- Toll-like receptor 7 agonist
- toll-like receptor agonist
- TLR7 MODULATOR
Cross-references
Synonyms
- GSK2245035
- 5L3SX16QBQ
- RefChem:144545
- UNII-5L3SX16QBQ
- SCHEMBL565847
- GTPL9254
- orb1709540
- SCHEMBL29368850
- LFMPVTVPXHNXOT-HNNXBMFYSA-N
- GLXC-15811
- EX-A10779
- NSC853260
- AKOS032954203
- NSC-853260
- compound 32 [PMID: 26861551]
- NCGC00856659-01
- DA-63925
- MS-26512
- HY-118250
- CS-0065520
- G16656
- T11482
- F3409-0744
- 6-amino-2-[(2S)-pentan-2-yl]oxy-9-(5-piperidin-1-ylpentyl)-7H-purin-8-one
- MWVXFHFYGZBEBN-DASCVMRKSA-N
- EX-A10780
- GSK-2245035 maleate salt
- H84791
- RefChem:201112
- UNII-P7H1142RHT
- GSK-2245035 maleate
- GSK2245035 Maleate
- P7H1142RHT
- orb1738515
- SCHEMBL14663495
Look up GSK-2245035 in the interactive SynDRA portal →